fbpx
© The Rialto Consultancy
BETA
v1.0
menu menu

Log on to your account

Forgotten password | Register

Welcome

Logout
Home | News & Insight | GSK secures Canadian made high blood pressure drug in US$950 million deal

GSK secures Canadian made high blood pressure drug in US$950 million deal

25th Feb 2026 | 04:40pm
GSK PLC agreed to buy 35Pharma Inc., a biotech with an early-stage drug for pulmonary hypertension, as the United Kingdom pharma giant boosts its pipeline of promising experimental therapies. Read More
Leadership
Gen Z pushes back on ‘performative availability’ as only 8% of workers say it won them a promotion
Leadership
The average worker would need to save for 52 years to claw their way out of the middle class and be classified as wealthy, research reveals